Cost Management Insights: SG&A Expenses for Perrigo Company plc and Veracyte, Inc.

Navigating SG&A Expenses: A Tale of Two Companies

In the ever-evolving landscape of corporate finance, understanding cost management is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Perrigo Company plc and Veracyte, Inc. over the past decade. Perrigo, a global leader in over-the-counter healthcare products, has seen its SG&A expenses grow by approximately 89% from 2014 to 2023. In contrast, Veracyte, a genomic diagnostics company, experienced a staggering 352% increase in the same period.

Key Insights

Perrigo's expenses peaked in 2023, reflecting strategic investments in marketing and administration. Meanwhile, Veracyte's rapid growth in SG&A expenses underscores its aggressive expansion and innovation in the healthcare sector. This comparison highlights the diverse strategies companies employ to manage costs while pursuing growth.

Conclusion

As businesses navigate the complexities of cost management, these insights offer valuable lessons in balancing growth and efficiency.